Integral Health Asset Management »

Lb Pharmaceuticals shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Lb Pharmaceuticals shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 100k 15.79

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Lb Pharmaceuticals

Deep Track Capital
RA Capital Management
TCG Crossover Management
Commodore Capital
Logos Global Management
Jpmorgan Chase & Co
BlackRock
Balyasny Asset Management
Vivo Capital
Jennison Associates
Alyeska Investment Group
Nantahala Capital Management
Citadel Advisors
Millennium Management
Soleus Capital Management

View all funds holding Lb Pharmaceuticals